Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Medical ImagingMolecular Imaging

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1514194

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1514194

Imaging Agents

PUBLISHED:
PAGES: 184 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Imaging Agents Market to Reach US$13.4 Billion by 2030

The global market for Imaging Agents estimated at US$9.8 Billion in the year 2023, is expected to reach US$13.4 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Diagnostic Radiopharmaceuticals, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$7.2 Billion by the end of the analysis period. Growth in the X-Ray / CT segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 7.9% CAGR

The Imaging Agents market in the U.S. is estimated at US$2.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 7.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Imaging Agents Market - Key Trends and Drivers Summarized

Diagnostic imaging agents, or contrast agents, are substances administered to patients to enhance the imaging process for disease diagnosis. These agents help radiopharmaceuticals emit energy using various methods, such as X-rays, gamma rays, sound waves, radio waves (MRI), and radioactive particles. By improving image contrast, they enable healthcare professionals to better visualize and assess body structures and detect abnormalities, providing critical insights for accurate diagnosis. Medical imaging is a critical tool that saves millions of lives by helping doctors diagnose diseases ranging from cancer to stroke. One of the most influential trends shaping this field is artificial intelligence (AI).

Technological progress in medical imaging continues to expand possibilities, leading to faster, safer, and more efficient imaging. Companies leverage advanced technology and globally accepted safety protocols to offer comprehensive imaging solutions. Key drivers in imaging advancements include AI, machine learning, and deep learning. These technologies are integrated into CT scans, MRIs, and ultrasounds to automate repetitive tasks with nearly perfect accuracy, cutting costs compared to traditional methods. Healthcare professionals increasingly rely on AI-based solutions to assess risk and tailor treatments, ensuring optimal, cost-effective therapy. Virtual and augmented reality (VR/AR) in 3D medical imaging technologies provide physicians with enhanced visualization of complex structures by creating 3D images from 2D MRI or CT scans. While the VR/AR market is still developing, its transformative potential in healthcare is becoming evident.

Nuclear imaging and wearable technology are also driving advancements in medical imaging. Nuclear imaging uses radiotracers to provide detailed insights into internal conditions such as cancer and Alzheimer's disease, with devices like the EXPLORER Total-body PET/CT Scanner improving efficiency. Wearables offer new applications in radiology, with the HD-DOT instrument and wearable ultrasound scanners enabling continuous brain and organ monitoring. These innovations are expanding diagnostic capabilities and improving patient care by providing earlier detection and more effective treatments.

Select Competitors (Total 23 Featured) -

  • Aytu BioScience Inc.
  • Bayer Healthcare Pharmaceuticals
  • Bracco Diagnostics Inc.
  • Curium
  • Daiichi Sankyo Company Limited
  • Eli Lilly
  • GE Healthcare
  • Guerbet Group
  • Lantheus Medical Imaging Inc.
  • Piramal Imaging SA
Show more
Product Code: MCP-3336

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Imaging Agents - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Drives Demand for Enhanced Diagnostic Imaging
    • Nanotechnology Innovations Open New Frontiers in Imaging Agent Efficacy
    • Expansion of Personalized Medicine Strengthens the Business Case for Targeted Imaging Agents
    • Aging Global Population Increases Utilization of Imaging Services
    • Technological Advancements in Imaging Equipment Spur Demand for Compatible Agents
    • Safety Concerns and Side Effects Prompt Research into Alternative Imaging Agents
    • Rise of Theranostics Integrates Diagnostic and Therapeutic Capabilities in Single Agents
    • Growing Healthcare Expenditure Worldwide Expands Addressable Market for Imaging Agents
    • Emergence of Multi-modal Imaging Techniques Catalyzes Innovations in Agent Development
    • Shift Towards Minimally Invasive Procedures Enhances the Role of Imaging Agents
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Imaging Agents Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Imaging Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnostic Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Diagnostic Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for X-Ray / CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for X-Ray / CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for X-Ray / CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Canada 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • JAPAN
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Japan 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • CHINA
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: China 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • EUROPE
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Imaging Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • FRANCE
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: France 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • GERMANY
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Germany 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Italy 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: UK 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Spain 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Russia 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Rest of Europe 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Imaging Agents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Asia-Pacific 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Australia 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • INDIA
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: India Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: India 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: South Korea 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Imaging Agents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Latin America 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Argentina 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Brazil 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Mexico 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Latin America 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Imaging Agents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Middle East 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Iran 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Israel 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Saudi Arabia 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UAE 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Middle East 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • AFRICA
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Africa 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!